Financials data is unavailable for this security.
View more
Year on year Merck KGaA 's revenues fell -5.57% from 22.23bn to 20.99bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 3.33bn to 2.82bn, a -15.07% decrease.
| Gross margin | 58.60% |
|---|---|
| Net profit margin | 12.90% |
| Operating margin | 16.41% |
| Return on assets | 5.41% |
|---|---|
| Return on equity | 9.54% |
| Return on investment | 6.70% |
More ▼
Cash flow in EURView more
In 2023, Merck KGaA increased its cash reserves by 6.90%, or 128.00m. The company earned 3.78bn from its operations for a Cash Flow Margin of 18.03%. In addition the company used 1.89bn on investing activities and also paid 1.73bn in financing cash flows.
| Cash flow per share | 2.18 |
|---|---|
| Price/Cash flow per share | 13.38 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in EURView more
| Current ratio | 1.33 |
|---|---|
| Quick ratio | 0.9103 |
| Total debt/total equity | 0.4017 |
|---|---|
| Total debt/total capital | 0.2861 |
More ▼
Growth rates in EUR
Year on year, growth in earnings per share excluding extraordinary items dropped -15.09%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 10.53% |
| EPS growth(5 years) | 21.40 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -6.81 |
More ▼
